Next Article in Journal
Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events
Next Article in Special Issue
Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
Previous Article in Journal
Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients
Previous Article in Special Issue
Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
 
 
Review

Article Versions Notes

Cancers 2020, 12(4), 1009; https://doi.org/10.3390/cancers12041009
Action Date Notes Link
article xml file uploaded 19 April 2020 15:50 CEST Original file -
article xml uploaded. 19 April 2020 15:50 CEST Update -
article pdf uploaded. 19 April 2020 15:50 CEST Version of Record https://www.mdpi.com/2072-6694/12/4/1009/pdf-vor
article html file updated 19 April 2020 15:52 CEST Original file -
article xml file uploaded 21 April 2020 09:18 CEST Update -
article xml uploaded. 21 April 2020 09:18 CEST Update https://www.mdpi.com/2072-6694/12/4/1009/xml
article pdf uploaded. 21 April 2020 09:18 CEST Updated version of record https://www.mdpi.com/2072-6694/12/4/1009/pdf
article html file updated 21 April 2020 09:19 CEST Update -
article html file updated 21 July 2022 02:24 CEST Update https://www.mdpi.com/2072-6694/12/4/1009/html
Back to TopTop